‘The general concept is a safer use approach’: how image and performance enhancing drug coaches negotiate safety through community care

References

• Atkinson, A., Van De Ven, K., Cunningham, M., de Zeeuw, T., Hibbert, E., Forlini, C., Barkoukis, V., & Sumnall, H. (2021). Performance and image enhancing drug interventions aimed at increasing knowledge among healthcare professionals (HCP): Reflections on the implementation of the Dopinglinkki e-module in Europe and Australia in the HCP workforce. The International Journal on Drug Policy, 95, 103141. https://doi.org/10.1016/j.drugpo.2021.103141
   PubMed Web of Science ®Google Scholar
• Bakken, S. A., Oksanen, A., & Demant, J. (2023). Capital in illegal online drug markets: How digital capital changes the cultural environment of drug dealing. Theoretical Criminology, 27(3), 421–438. https://doi.org/10.1177/13624806221143365
   Web of Science ®Google Scholar
• Bates, G., McVeigh, J., & Leavey, C. (2021). Looking beyond the provision of injecting equipment to people who use anabolic androgenic steroids: Harm reduction and behavior change goals for UK policy. Contemporary Drug Problems, 48(2), 135–150. https://doi.org/10.1177/0091450921998701
   Google Scholar
• Bourdieu, P. (1984). A social critique of the judgement of taste. Traducido del francés por R. Nice. Routledge.
   Google Scholar
• Brookfield, S., Fitzgerald, L., Selvey, L., & Maher, L. (2019). Turning points, identity, and social capital: A meta-ethnography of methamphetamine recovery. The International Journal on Drug Policy, 67, 79–90. https://doi.org/10.1016/j.drugpo.2019.02.002
   PubMed Web of Science ®Google Scholar
• Chegeni, R., Notelaers, G., Pallesen, S., & Sagoe, D. (2021). Aggression and psychological distress in male and female anabolic-androgenic steroid users: A multigroup latent class analysis. Frontiers in Psychiatry, 12, 629428. https://doi.org/10.3389/fpsyt.2021.629428
   PubMed Web of Science ®Google Scholar
• Cox, L., & Paoli, L. (2023). Social media influencers, YouTube & performance and image enhancing drugs: A narrative-typology. Performance Enhancement & Health, 11(4), 100266. https://doi.org/10.1016/j.peh.2023.100266
   Google Scholar
• Douglas, M. P. (1966). Danger: An analysis of concepts of pollution and taboo. Routledge & Kegan Paul.
   Google Scholar
• Duff, C. (2012). Accounting for context: Exploring the role of objects and spaces in the consumption of alcohol and other drugs. Social & Cultural Geography, 13(2), 145–159. https://doi.org/10.1080/14649365.2012.655765
   Web of Science ®Google Scholar
• Dunn, M., Mulrooney, K. J., Forlini, C., van de Ven, K., & Underwood, M. (2021). The pharmaceuticalisation of ‘healthy’ageing: Testosterone enhancement for longevity. The International Journal on Drug Policy, 95, 103159. https://doi.org/10.1016/j.drugpo.2021.103159
   PubMed Web of Science ®Google Scholar
• Dunn, M., Piatkowski, T., Whiteside, B., & Eu, B. (2023). Exploring the experiences of general practitioners working with patients who use performance and image enhancing drugs. Performance Enhancement & Health, 11(2), 100247. 100247. https://doi.org/10.1016/j.peh.2023.100247
   Google Scholar
• Francia, L., Berg, A., Lam, T., Morgan, K., & Nielsen, S. (2023). “The peer workers, they get it”–how lived experience expertise strengthens therapeutic alliances and alcohol and other drug treatment-seeking in the hospital setting. Addiction Research & Theory, 31(2), 106–113. https://doi.org/10.1080/16066359.2022.2124245
   Web of Science ®Google Scholar
• Fraser, S., Fomiatti, R., Moore, D., Seear, K., & Aitken, C. (2020). Is another relationship possible? Connoisseurship and the doctor–patient relationship for men who consume performance and image-enhancing drugs. Social Science & Medicine (1982), 246, 112720. https://doi.org/10.1016/j.socscimed.2019.112720
   PubMed Web of Science ®Google Scholar
• Gibbs, N. (2023). # Sponseredathlete: The marketing of image and performance enhancing drugs on Facebook and Instagram. Trends in Organized Crime, 1–40. https://doi.org/10.1007/s12117-023-09491-4
   PubMed Web of Science ®Google Scholar
• Gibbs, N., Cox, L., & Turnock, L. (2022). Anabolics coaching: Emic harm reduction or a public health concern? Performance Enhancement & Health, 10(3), 100227. https://doi.org/10.1016/j.peh.2022.100227
   Google Scholar
• Gibbs, N., Salinas, M., & Turnock, L. (2022). Post-industrial masculinities and gym culture: Graft, craft, and fraternity. The British Journal of Sociology, 73(1), 220–236. https://doi.org/10.1111/1468-4446.12921
   PubMed Web of Science ®Google Scholar
• Goodyear, T., Brown, H., Browne, A. J., Hoong, P., Ti, L., & Knight, R. (2021). “Stigma is where the harm comes from”: Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs. The International Journal on Drug Policy, 96, 103238. https://doi.org/10.1016/j.drugpo.2021.103238
   PubMed Web of Science ®Google Scholar
• Griffiths, S., Henshaw, R., McKay, F. H., & Dunn, M. (2017). Post-cycle therapy for performance and image enhancing drug users: A qualitative investigation. Performance Enhancement & Health, 5(3), 103–107. https://doi.org/10.1016/j.peh.2016.11.002
   Google Scholar
• Harrigan, P., Daly, T. M., Coussement, K., Lee, J. A., Soutar, G. N., & Evers, U. (2021). Identifying influencers on social media. International Journal of Information Management, 56, 102246. https://doi.org/10.1016/j.ijinfomgt.2020.102246
   Web of Science ®Google Scholar
• Harvey, O., Keen, S., Parrish, M., & van Teijlingen, E. (2019). Support for people who use anabolic androgenic steroids: A systematic scoping review into what they want and what they access. BMC Public Health, 19(1), 1024. https://doi.org/10.1186/s12889-019-7288-x
   PubMed Web of Science ®Google Scholar
• Henning, A., & Andreasson, J. (2022). Preventing, producing, or reducing harm? Fitness doping risk and enabling environments. Drugs: Education, Prevention and Policy, 29(1), 95–104. https://doi.org/10.1080/09687637.2020.1865273
   Web of Science ®Google Scholar
• Hill, S. A., & Waring, W. S. (2019). Pharmacological effects and safety monitoring of anabolic androgenic steroid use: Differing perceptions between users and healthcare professionals. Therapeutic Advances in Drug Safety, 10, 2042098619855291. https://doi.org/10.1177/2042098619855291
   Web of Science ®Google Scholar
• Holt, M. (2014). Sex, drugs, and HIV: Let’s avoid panic. The Lancet HIV, 1(1), e4–e5. https://doi.org/10.1016/S2352-3018(14)70007-4
   PubMed Web of Science ®Google Scholar
• Hope, V., Underwood, M., Mulrooney, K., Mazanov, J., van de Ven, K., & McVeigh, J. (2021). Human enhancement drugs: Emerging issues and responses. The International Journal on Drug Policy, 95, 103459. https://doi.org/10.1016/j.drugpo.2021.103459
   PubMed Web of Science ®Google Scholar
• James, E., & Wynn, L. (2022). Testosterone vs. steroids: Comparing the disciplined bodywork projects of performance and image enhancing drug users in Australia. The International Journal on Drug Policy, 107, 103776. https://doi.org/10.1016/j.drugpo.2022.103776
   PubMed Web of Science ®Google Scholar
• Kimergård, A. (2015). A qualitative study of anabolic steroid use amongst gym users in the United Kingdom: Motives, beliefs and experiences. Journal of Substance Use, 20(4), 288–294. https://doi.org/10.3109/14659891.2014.911977
   Web of Science ®Google Scholar
• Kippax, S., & Race, K. (2003). Sustaining safe practice: Twenty years on. Social Science & Medicine, 57(1), 1–12. https://doi.org/10.1016/S0277-9536(02)00303-9
   PubMed Web of Science ®Google Scholar
• Kotzé, J., & Antonopoulos, G. A. (2021). Boosting bodily capital: Maintaining masculinity, aesthetic pleasure and instrumental utility through the consumption of steroids. Journal of Consumer Culture, 21(3), 683–700. https://doi.org/10.1177/1469540519846196
   Google Scholar
• McVeigh, J., & Bates, G. (2022). Stigma and the use of anabolic androgenic steroids by men in the united kingdom. In Drugs, identity and stigma (pp. 121–146). Springer.
   Google Scholar
• McVeigh, J., & Begley, E. (2017). Anabolic steroids in the UK: An increasing issue for public health. Drugs: Education, Prevention and Policy, 24(3), 278–285. https://doi.org/10.1080/09687637.2016.1245713
   Web of Science ®Google Scholar
• Monaghan, L. (1999). Challenging medicine? Bodybuilding, drugs and risk. Sociology of Health & Illness, 21(6), 707–734. https://doi.org/10.1016/S0277-9536(01)00195-2
   Web of Science ®Google Scholar
• Monaghan, L. (2001). Looking good, feeling good: The embodied pleasures of vibrant physicality. Sociology of Health & Illness, 23(3), 330–356. https://doi.org/10.1111/1467-9566.00255
   Web of Science ®Google Scholar
• Monaghan, L. F. (2002a). Vocabularies of motive for illicit steroid use among bodybuilders. Social Science & Medicine (1982), 55(5), 695–708. https://doi.org/10.1016/S0277-9536(01)00195-2
   PubMed Web of Science ®Google Scholar
• Monaghan, L. (2002b). Bodybuilding, drugs and risk. Routledge.
   Google Scholar
• Neale, J. (2016). Iterative categorization (IC): A systematic technique for analysing qualitative data. Addiction (Abingdon, England), 111(6), 1096–1106. https://doi.org/10.1111/add.13314
   PubMed Web of Science ®Google Scholar
• Neale, J. (2021). Iterative categorisation (IC)(part 2): Interpreting qualitative data. Addiction (Abingdon, England), 116(3), 668–676. https://doi.org/10.1111/add.15259
   PubMed Web of Science ®Google Scholar
• Paoli, L., & Cox, L. T. J. (2024). Across the spectrum of legality: The market activities of influencers specialized in steroids and other performance and image enhancing drugs. The International Journal on Drug Policy, 123, 104246. https://doi.org/10.1016/j.drugpo.2023.104246
   PubMed Web of Science ®Google Scholar
• Paquette, C. E., Syvertsen, J. L., & Pollini, R. A. (2018). Stigma at every turn: Health services experiences among people who inject drugs. The International Journal on Drug Policy, 57, 104–110. https://doi.org/10.1016/j.drugpo.2018.04.004
   PubMed Web of Science ®Google Scholar
• Parkin, S. (2016). Habitus and drug using environments: Health, place and lived-experience. Routledge.
   Google Scholar
• Paulus, T. M., Woodside, M., & Ziegler, M. F. (2010). “I tell you, it’sa journey, isn’t it?” Understanding collaborative meaning making in qualitative research. Qualitative Inquiry, 16(10), 852–862. https://doi.org/10.1177/1077800410383124
   Web of Science ®Google Scholar
• Piatkowski, T., Gibbs, N., & Dunn, M. (2023a). Beyond the law: Exploring the impact of criminalising anabolic-androgenic steroid use on help-seeking and health outcomes in Australia. Journal of Criminology, 57(1), 62–82. https://doi.org/10.1177/26338076231209044
   Web of Science ®Google Scholar
• Piatkowski, T., Gibbs, N., & Dunn, M. (2023b). “I feel like I’m walking the line; one side it’s manageable, the other side it’s f** king prison”: Exploring the dual nature of user-manufacturers of image and performance enhancing drugs. Deviant Behavior, 1–18. https://doi.org/10.1080/01639625.2023.2250896
   Web of Science ®Google Scholar
• Piatkowski, T. M., Neumann, D. L., & Dunn, M. (2023c). ‘My mind pretty much went to mush’: A qualitative exploration of trenbolone in the performance and image enhancing drug community. Drug and Alcohol Review, 42(6), 1566–1576. https://doi.org/10.1111/DAR.13656
   PubMed Web of Science ®Google Scholar
• Piatkowski, T. M., Neumann, D. L., Keane, C., & Dunn, M. (2023d). “More drugs means more stress on my body”: Exploring enhancement and health among elite strength athletes who use performance and image enhancing drugs. Addiction Research & Theory, 0(0), 1–6. https://doi.org/10.1080/16066359.2023.2271839
   Google Scholar
• Piatkowski, T., Benn, S., Ayurzana, L., King, M., McMillan, S., & Hattingh, L. (2024). Exploring the role of community pharmacies as a harm reduction environment for anabolic-androgenic steroid consumers: Triangulating the perspectives of consumers and pharmacists. Harm Reduction Journal, 21(1), 59. (https://doi.org/10.1186/s12954-024-00972-5
   PubMed Web of Science ®Google Scholar
• Pope, H. G., Kanayama, G., Ionescu-Pioggia, M., & Hudson, J. I. (2004). Anabolic steroid users’ attitudes towards physicians. Addiction (Abingdon, England), 99(9), 1189–1194. https://doi.org/10.1111/j.1360-0443.2004.00781.x
   PubMed Web of Science ®Google Scholar
• Rance, J., Rhodes, T., Fraser, S., Bryant, J., & Treloar, C. (2018). Practices of partnership: Negotiated safety among couples who inject drugs. Health (London, England: 1997), 22(1), 3–19. https://doi.org/10.1177/1363459316660859
   PubMed Web of Science ®Google Scholar
• Rance, J., Treloar, C., Fraser, S., Bryant, J., & Rhodes, T. (2017). “Don’t think I’m going to leave you over it”: Accounts of changing hepatitis C status among couples who inject drugs. Drug and Alcohol Dependence, 173, 78–84. https://doi.org/10.1016/j.drugalcdep.2016.12.020
   PubMed Web of Science ®Google Scholar
• Rhodes, T., Rance, J., Fraser, S., & Treloar, C. (2017). The intimate relationship as a site of social protection: Partnerships between people who inject drugs. Social Science & Medicine (1982), 180, 125–134. https://doi.org/10.1016/j.socscimed.2017.03.012
   PubMed Web of Science ®Google Scholar
• Rhodes, T., & Treloar, C. (2008). The social production of hepatitis C risk among injecting drug users: A qualitative synthesis. Addiction (Abingdon, England), 103(10), 1593–1603. https://doi.org/10.1111/j.1360-0443.2008.02306.x
   PubMed Web of Science ®Google Scholar
• Richardson, A., & Antonopoulos, G. A. (2019). Anabolic-androgenic steroids (AAS) users on AAS use: Negative effects,’code of silence’, and implications for forensic and medical professionals. Journal of Forensic and Legal Medicine, 68, 101871. https://doi.org/10.1016/j.jflm.2019.101871
   PubMed Web of Science ®Google Scholar
• Santos, G. H., & Coomber, R. (2017). The risk environment of anabolic–androgenic steroid users in the UK: Examining motivations, practices and accounts of use. The International Journal on Drug Policy, 40, 35–43. https://doi.org/10.1016/j.drugpo.2016.11.005
   PubMed Web of Science ®Google Scholar
• Seear, K., Gray, R., Fraser, S., Treloar, C., Bryant, J., & Brener, L. (2012). Rethinking safety and fidelity: The role of love and intimacy in hepatitis C transmission and prevention. Health Sociology Review, 21(3), 272–286. https://doi.org/10.5172/hesr.2012.21.3.272
   Web of Science ®Google Scholar
• Treloar, C., Rance, J., & Backmund, M. (2013). Understanding barriers to hepatitis C virus care and stigmatization from a social perspective. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America, 57 Suppl 2(suppl_2), S51–S55. https://doi.org/10.1093/cid/cit263
   PubMedGoogle Scholar
• Treloar, C., Rance, J., Bryant, J., & Fraser, S. (2016). Harm reduction workers and the challenge of engaging couples who inject drugs in hepatitis C prevention. Drug and Alcohol Dependence, 168, 170–175. https://doi.org/10.1016/j.drugalcdep.2016.09.010
   PubMed Web of Science ®Google Scholar
• Turnock, L. (2021). Supplying Steroids Online: The cultural and market contexts of enhancement drug supply on one of the World’s largest fitness & bodybuilding forums. PPRI Criminology series. Plymouth Policy Research Institute.
   Google Scholar
• Underwood, M. (2019). The unintended consequences of emphasising blood-borne virus in research on, and services for, people who inject image and performance enhancing drugs: A commentary based on enhanced bodybuilder perspectives. The International Journal on Drug Policy, 67, 19–23. https://doi.org/10.1016/j.drugpo.2018.11.005
   PubMed Web of Science ®Google Scholar
• van Beek, I., & Chronister, K. (2015). Performance and image enhancing drug injectors’ access to needle syringe programes: Responding to a public policy dilemma. The International Journal on Drug Policy, 26(9), 868–874. https://doi.org/10.1016/j.drugpo.2015.05.009
   PubMed Web of Science ®Google Scholar
• van de Ven, K., Boardley, I., & Chandler, M. (2022). Identifying best-practice amongst health professionals who work with people using image and performance enhancing drugs (IPEDs) through participatory action research. Qualitative Research in Sport, Exercise and Health, 14(2), 199–215. https://doi.org/10.1080/2159676X.2021.1898457
   Web of Science ®Google Scholar
• Wacquant, L. (2002). Scrutinizing the street: Poverty, morality, and the pitfalls of urban ethnography. American Journal of Sociology, 107(6), 1468–1532. https://doi.org/10.1086/340461
   Web of Science ®Google Scholar
• Ward, P., & Coates, A. (2006). ‘We shed tears, but there is no one there to wipe them up for us’: Narratives of (mis) trust in a materially deprived community. Health (London, England: 1997), 10(3), 283–301. https://doi.org/10.1177/1363459306064481
   PubMed Web of Science ®Google Scholar
• Zahnow, R., McVeigh, J., Ferris, J., & Winstock, A. (2017). Adverse effects, health service engagement, and service satisfaction among anabolic androgenic steroid users. Contemporary Drug Problems, 44(1), 69–83. https://doi.org/10.1177/0091450917694268
   Google Scholar